Simplify Logo

Full-Time

Associate Director/Director

Procure to Pay

Confirmed live in the last 24 hours

Verve Therapeutics

Verve Therapeutics

201-500 employees

Developing gene editing therapies for heart disease

Biotechnology
Healthcare

Expert

Boston, MA, USA

Category
Procurement & Sourcing
Supply Chain Management
Operations & Logistics
Required Skills
Communications
Coupa
Requirements
  • Bachelor’s degree in finance, accounting, economics, business, or a related field
  • At least 9 years of relevant strategic sourcing and purchasing experience with at least 4 years’ experience within the biotech industry.
  • Experience managing the accounts payable process.
  • Comprehensive knowledge of strategic sourcing best practices and proven negotiation skills.
  • Hands on system related skill, including Coupa or similar platform.
  • Solid analytical skills and solution-driven thinking; collects and researches data; uses intuition and experience to complement data.
  • Identifies and resolves problems in a timely manner; develops alternative solutions; works well in group problem solving situations; presents ideas and information in a manner that gets others’ attention.
  • Demonstrated communication and teamwork capabilities and the ability to work well across the organization.
  • Strong project management skills, including the ability to prioritize, balance and manage multiple efforts with strong results/goal orientation.
Responsibilities
  • Works closely with each function to lead, oversee and coordinate the negotiation strategies / efforts and processes on purchase agreements and vendor selection that results in quality, delivery, and cost effectiveness.
  • Partners with departments to understand purchasing needs and adequate funds are available.
  • Manages supplier relationships including developing and tracking of key performance indicators for the category of spend, facilitating key/strategic supplier-company business meetings, and supporting key operational due diligence efforts.
  • Develops strong working knowledge of spend management platform and works closely with systems consultants to continuously improve and automate new features.
  • Develops and maintains Verve’s purchasing policy; ensuring our practices are in alignment and the policy is reflective and facilitates the needs of the business.
  • Strategic oversight of the Accounts Payable function enabling streamlined processes and optimized workflow
  • Ensure timely and accurate payments to vendors, including vendor onboarding and resolution of escalation issues.
  • Oversee and properly maintain vendor records as well as required annual reporting for vendor IRS filings
  • Managerial responsibilities for a team including oversight of day-to-day work assignments and performance, mentor, provide feedback, and train team.
  • Other duties as assigned.

Verve Therapeutics is developing single-course gene editing medicines to address cardiovascular disease, with a focus on precision genetic editing technologies to lower LDL cholesterol and triglyceride levels. Their lead program, VERVE-101, targets heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

5%

1 year growth

5%

2 year growth

40%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant financial backing, including a $63 million Series A2 financing and $60 million from Eli Lilly, positions Verve for robust R&D and clinical trial activities.
  • The potential for a 'one-and-done' treatment for cardiovascular diseases could revolutionize the field and offer a high-impact, life-saving solution.
  • Early-stage success and strategic partnerships could lead to lucrative licensing deals and further investment opportunities.

What critics are saying

  • The clinical-stage nature of Verve's therapies means they are still years away from potential market approval, posing a long-term risk.
  • The recent stock price drop following a public offering indicates market volatility and potential investor uncertainty.

What makes Verve Therapeutics unique

  • Verve Therapeutics focuses on gene-editing therapies specifically for cardiovascular diseases, setting it apart from other CRISPR-based companies that target a broader range of conditions.
  • Their 'one-and-done' gene-editing approach aims to provide a single, curative treatment, which is a significant advantage over traditional, ongoing therapies.
  • Partnerships with major pharmaceutical companies like Eli Lilly enhance their credibility and provide substantial financial and research support.